- Liver Disease and Dietby Pete CelanoThe Liver Disease News article “Steatotic liver disease and diet: Foods to eat and avoid” of March 4, 2026, by Marisa Wexler, MS has news you can use. Key Takeaways… Read more: Liver Disease and Diet
- Acute Liver Failureby Pete CelanoSummary: Acute Liver Failure: 5 Things to Know By Eugenia Tsai, MD (May 8, 2026), and here’s the URL of the article on Medscape: This article reviews the key clinical… Read more: Acute Liver Failure
- ACLF Classification Reconsideredby Brandon TudorThis paper titled “Organ failure-based clinical classification at onset of acute-on-chronic liver failure: a prospective multicenter cohort study” from Scientific Reports proposes a new way to classify acute-on-chronic liver failure… Read more: ACLF Classification Reconsidered
- Cirrhosis Shiftby Pete CelanoThe article by Elliott Tapper, MD entitled “The Changing Face of Cirrhosis” is a must read. It was published April 15, 2026 in docwirenews. Summary- 🔑 The Core Shift Cirrhosis… Read more: Cirrhosis Shift
- DDW 2026by David SiresLiverRight’s David Sires and Kevin Harlen are at DDW in Chicago. Digestive Disease Week® (DDW) 2026 takes place in Chicago, IL, from May 2–5, 2026, offering a premier forum for GI… Read more: DDW 2026
- AI and the Healthcare Effectby Brandon TudorSummary of the article from Pitchbook titled “PitchBook Analyst Note: AI Will Deliver Care to Billions and Break the System That Built It.” 🧠 Core thesis AI will massively expand… Read more: AI and the Healthcare Effect
- Hepatitis C in America Todayby Pete CelanoEnlightening article from Roll Call: “Deadly liver disease, rooted out elsewhere, retains grip on US“. Summary: Bottom line The article argues that the U.S. has the tools to eliminate hepatitis… Read more: Hepatitis C in America Today
- Hello, FQHCsby David SiresAs of 2026, there are ~1,359 FQHC (Federally Qualified Health Center) organizations in the United States, operating more than 16,300 service delivery sites. These sites are located across all 50… Read more: Hello, FQHCs
- HCV Testing Drives Savingsby David SiresGreat article here- Timely hepatitis C screening helps US patients avoid costly illness (Investing in early treatment saves thousands in healthcare expenses over time) from April 23, 2026 in Liver… Read more: HCV Testing Drives Savings
- Hello, KidneyXby Pete CelanoLiver needs one of these: HHS Announces $4 Million KidneyX EMPOWER Prize Challenge and Health Technology Project to Advance Living Kidney Donation and Patient-Centered Innovation. Key quote: The $4 million… Read more: Hello, KidneyX
- Today is World Liver Dayby Brandon Tudor
- World Liver Dayby David SiresMost liver disease is preventable. April 19, 2026 is World Liver Day. From the site https://worldliverday.org/ — Solid Habits, Strong Liver. Your liver is a powerhouse: it filters blood, breaks… Read more: World Liver Day
- Transplant Administration Explainedby Pete CelanoLisa Norris is the Managing Director & Principal at Transplant Leadership Institute LLC, and a veteran Transplant Services Director. This is her superb book relating to the $11 billion in… Read more: Transplant Administration Explained
- How Liver Disease Can Become Liver Cancerby Brandon TudorLiver disease can turn into liver cancer through a gradual, multi-step process driven by chronic damage, inflammation, and cell mutation. Here’s the clearest way to understand it: 1. Chronic liver… Read more: How Liver Disease Can Become Liver Cancer
- Mobile Telemedicine for Treating Hepatitisby Pete CelanoThe JAMA Network Open article of 01/26/2026 titled “Mobile Telemedicine for Treating Chronic Hepatitis C Among Rural People Who Inject Drugs” is revelatory– 🧠 Study Overview 🔑 Key Findings 💡… Read more: Mobile Telemedicine for Treating Hepatitis
- MASH Explainerby David SiresThe article “8 takeaways about MASH, an increasingly common liver disease associated with obesity” from Managed Care Executive dated April 7, 2026, has a cogent analysis on MASLD/MASH. Summarized– 8… Read more: MASH Explainer
- OSA and Liver Diseaseby Pete CelanoHere we summarize “Association between metabolic dysfunction-associated steatotic liver disease and obstructive sleep apnea: a nationwide retrospective cohort study” from Scientific Reports (Nature Portfolio), March 2026. 🎯 Objective The study… Read more: OSA and Liver Disease
- PBC Medicationsby Brandon TudorThere’s an important article titled “Par for the course? Comparative effectiveness of PPAR agonists in PBC” from April 2026 in Hepatology by Robert M. Wilechansky, and it’s summarized below– 🧠… Read more: PBC Medications
- Binge Drinking and Liver Damageby Brandon TudorHere’s a summary on this April 2, 2026 article from USC Keck – “Occasional Heavy Drinking May Triple the Risk of Liver Damage.” 🧠 Key takeaway Even occasional heavy drinking… Read more: Binge Drinking and Liver Damage
- HCV and Incarcerated Peopleby Pete CelanoThis article is worth reading, from JAMA Internal Medicine dated March23, 2026: “Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies“. 🎯 Objective The study evaluated whether screening,… Read more: HCV and Incarcerated People
- New Wave of Disruptorsby Pete CelanoUS Healthcare is changing. Fast. There’s supernormal change– perhaps transformation, even, as four factors collide. From the March 10, 2026 in The Economist: A new wave of disrupters takes on… Read more: New Wave of Disruptors
- March is Liver Monthby David Sires
- Living Donor Need in Liverby Brandon TudorThe March 2026 journal article titled “Increasing Transplant Access for Low MELD Patients in the United States: Do We Still Need to Increase Adult Living Donor Liver Transplantation?” is thought… Read more: Living Donor Need in Liver
- Consortium to Find Hepatitis B cureby Pete CelanoMajor Headline from March 10, 2026: Johns Hopkins leads $24M multinational consortium to find hepatitis B cure With NIH funding, the group will pursue research and patient care approaches for… Read more: Consortium to Find Hepatitis B cure
- Sugary Drinks and Liver Fatby Brandon Tudor🧠 Key takeaway Sugary drinks—especially those high in fructose—promote fat buildup in the liver (hepatic steatosis) through multiple metabolic pathways, increasing the risk of fatty liver disease. ⚙️ How sugary… Read more: Sugary Drinks and Liver Fat
- Helio Genomics and Quest Diagnosticsby Pete CelanoHelio Genomics is a LiverRight partner and had big news on March 18, 2026: Helio Genomics to Make HelioLiver™ Cancer Test Accessible to Quest Diagnostics’ Providers “Quest’s Infrastructure to Enable… Read more: Helio Genomics and Quest Diagnostics
- Cardiometabolic Risk Factors and Liver Fibrosisby Brandon TudorThe article “Cardiometabolic Risk Factors Increase Likelihood of Liver Fibrosis More in Women Than Men” from March 16, 2026, is revealing. It’s from a study published in JAMA Network Open. 🔬… Read more: Cardiometabolic Risk Factors and Liver Fibrosis
- LiverRight Appointment Guaranteeby Pete CelanoOur Pledge: Same-Week Video Visit with one of our expert liver providers. In all 50 US states + DC.
- New Models in Alcohol-Associated Liver Diseaseby Brandon TudorHer’s asummary of the article published online February 25, 2026 in Gastroenterology —“New Model Performs Well for Detecting Alcohol-Associated Liver Disease” Bottom line:The study introduces a simple, scalable screening model using… Read more: New Models in Alcohol-Associated Liver Disease